Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for PLIANT THERAPEUTICS, INC Common Stock (PLRX).
- Disclosed ownership: 0.9%.
- Date of event: 31 Dec 2025.
MORGAN STANLEY - 31 Dec 2025 SCHEDULE 13G/A Report for PLIANT THERAPEUTICS, INC Common Stock (PLRX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- PLRX
- Shares outstanding
- 60,580,889 shares
- Disclosed Ownership
- 545,228 shares
- Ownership
- 0.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 Jan 2026, 16:03:14 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 06 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 0.9% ownership in PLIANT THERAPEUTICS, INC Common Stock (PLRX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 06 Aug 2025.
- Current filing was accepted on 08 Jan 2026, 16:03.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 0.9% | 545,228 | 0 | 544,224 | Christopher O'Hara | Authorized Signatory, Morgan Stanley |